RxDoctor Payments Data

Davin Valenti

Nurse Practitioner · Spokane, WANPI 1053873158

Payments from drug & device makers

$2,968in general payments, 2019–2025

Across 27 payments — averaging $109.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Actelion Pharmaceuticals US, Inc.$377
  • Abiomed$327
  • Getinge USA Sales, LLC$279
  • Medtronic$144
  • Abbott$129
  • plus $279 from 3 others

What the payments were for

  • Travel & lodging$1,23442%
  • Food & beverage$1,73558%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.7$1,434
Actelion Pharmaceuticals US, Inc.3$377
Abiomed5$327
Getinge USA Sales, LLC7$279
Medtronic1$144
Abbott1$129
Novo Nordisk1$125
Sawtooth Surgical Solutions Inc1$93
Baxter Healthcare1$61

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,968 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.

See all nurse practitioner providers in Washington

Medicare billing

Part B allowed, 2024
$12,930
Medicare patients
68
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate12$208
Oxycodone Hcl33$155
Potassium Chloride25$149
Amiodarone Hcl11$142
Atorvastatin Calcium12$80
Warfarin Sodium12$58
Metoprolol Tartrate15$45
Furosemide28$40

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →